Contemporary trend of reduced-dose non-vitamin K anticoagulants in Japanese patients with atrial fibrillation: A cross-sectional analysis of a multicenter outpatient registry-Reference-Cited by-同舟云学术

Contemporary trend of reduced-dose non-vitamin K anticoagulants in Japanese patients with atrial fibrillation: A cross-sectional analysis of a multicenter outpatient registry

Published:2019-01 Issue:1 Volume:73 Page:14-21
ISSN:0914-5087
Container-title:Journal of Cardiology
language:en
Short-container-title:Journal of Cardiology

Author:

Ono Tomohiko,Ikemura Nobuhiro,Kimura Takehiro,Ueda Ikuko,Tanaka Hiroaki,Tokuda Hanako,Yajima Noriyuki,Matsumura Keisuke,Suzuki Masahiro,Fukuda Keiichi,Kohsaka Shun,Takatsuki Seiji

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study;Wolf;Stroke,1991

2. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study;Marini;Stroke,2005

3. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials;Ruff;Lancet,2014

4. Non-vitamin K antagonist oral anticoagulants have better efficacy and equivalent safety compared to warfarin in elderly patients with atrial fibrillation: a systematic review and meta-analysis;Kim;J Cardiol,2018

5. Predictive factors for bleeding during treatment with rivaroxaban and warfarin in Japanese patients with atrial fibrillation – subgroup analysis of J-ROCKET AF;Hori;J Cardiol,2016

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence, contemporary trends and associated factors of potentially inappropriate prescription of edoxaban in real‐world clinical practice: A subanalysis of the SUNSHINE registry;British Journal of Clinical Pharmacology;2023-12-13

2. Rules for using reduced doses of non-vitamin K antagonist oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation. The expert opinion of the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society;Kardiologia Polska;2022-12-30

3. Prevalence, risk factors, and prediction of inappropriate use of non-vitamin K antagonist oral anticoagulants in elderly Chinese patients with atrial fibrillation: A study protocol;Frontiers in Cardiovascular Medicine;2022-08-24

4. Clinical Events with Edoxaban in South Korean and Taiwanese Atrial Fibrillation Patients in Routine Clinical Practice;Journal of Clinical Medicine;2021-11-16

5. Factors associated with inappropriate reduced doses of non-vita-min K antagonist oral anticoagulants in patients with atrial fibrillation;The Scientific Notes of the Pavlov University;2021-10-30